Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)

Steris' (STE) quarterly Non-Current Deferred Tax Liability came in at $390.7 million in Q1 2026, down 3.22% year-on-year from $403.7 million in Q1 2025, and down 5.74% quarter-over-quarter from $414.5 million in Q4 2025.

Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends

Steris' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $390.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 3.22% year-over-year to $390.7 million in Q1 2026; TTM through Mar 2026 was $390.7 million, a 3.22% decrease from a year earlier, with the FY2026 full-year figure at $390.7 million, down 3.22% from the prior year.
  • Non-Current Deferred Tax Liability fell to $390.7 million in Q1 2026 per STE's latest filing, from $414.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $790.8 million in Q2 2022 and bottomed at $390.7 million in Q1 2026.
  • The 5-year median for Non-Current Deferred Tax Liability is $479.7 million (2024), against an average of $550.6 million.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 229.57% in 2022 and decreased 27.04% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $724.6 million in 2022, then dropped by 14.29% to $621.1 million in 2023, then dropped by 27.04% to $453.1 million in 2024, then retreated by 8.52% to $414.5 million in 2025, then dropped by 5.74% to $390.7 million in 2026.
  • Per Business Quant, the three latest STE Non-Current Deferred Tax Liability figures stand at $390.7 million (Q1 2026), $414.5 million (Q4 2025), and $412.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 390.70 Mn
Mar 31, 2026 390.70 Mn
Dec 31, 2025 414.50 Mn
Dec 31, 2025 414.50 Mn
Sep 30, 2025 412.00 Mn
Sep 30, 2025 412.00 Mn
Jun 30, 2025 411.40 Mn
Jun 30, 2025 411.40 Mn
Mar 31, 2025 403.70 Mn
Mar 31, 2025 403.70 Mn
Dec 31, 2024 453.13 Mn
Dec 31, 2024 453.13 Mn
Sep 30, 2024 462.74 Mn
Sep 30, 2024 462.74 Mn
Jun 30, 2024 456.47 Mn
Jun 30, 2024 456.47 Mn
Mar 31, 2024 479.69 Mn
Mar 31, 2024 479.69 Mn
Dec 31, 2023 621.07 Mn
Dec 31, 2023 621.07 Mn